Protagonist Therapeutics (PTGX) Total Non-Current Liabilities (2015 - 2021)
Protagonist Therapeutics (PTGX) posted Total Non-Current Liabilities of $43.4 million for Q3 2021, down 7.01% sequentially from $46.7 million in Q2 2021, and down 8.76% YoY from $47.6 million in Q3 2020.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Total Non-Current Liabilities (2015 - 2021) Analysis & Trends
Protagonist Therapeutics has reported Total Non-Current Liabilities for 3 years, with the latest figure at $43.4 million in Q3 2021.
- Quarterly Total Non-Current Liabilities fell 8.76% year-over-year to $43.4 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $43.4 million (down 8.76% YoY) and the FY2020 annual result came in at $44.7 million, changed N/A from the prior year.
- Total Non-Current Liabilities declined to $43.4 million in Q3 2021 per PTGX's latest filing, from $46.7 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $57.4 million in Q2 2020 and troughed at $38.6 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 3.92 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.53 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.88 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.32 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Protagonist Therapeutics | 9.61 Bn | 9.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 43.39 Mn |
| Jun 30, 2021 | 46.66 Mn |
| Mar 31, 2021 | 38.62 Mn |
| Dec 31, 2020 | 44.74 Mn |
| Sep 30, 2020 | 47.56 Mn |
| Jun 30, 2020 | 57.40 Mn |
| Dec 31, 2015 | 3.13 Mn |